What should you know about multicentric glioblastoma?

Glioblastoma is an aggressive primary brain tumour. In a multicentric pattern, separate tumour areas are present without a single obvious connecting pathway. Symptoms depend on the regions involved and may include headaches, seizures, weakness, speech changes, memory problems or altered alertness. MRI helps map the areas and surrounding swelling. A biopsy or tissue obtained during surgery is examined to confirm the diagnosis and provide information that guides the plan. The position of each area matters because brain tissue controls movement, language, vision and other functions.

Ask for review by a multidisciplinary neuro-oncology team. The team may discuss brain tumour surgery to obtain tissue or remove safely accessible tumour, followed by radiotherapy and chemotherapy. Steroids may be used to reduce swelling, and anti-seizure medicine may be considered when seizures occur. Treatment is adjusted to symptoms, imaging, tissue findings, general health and personal goals. A clinical trial may be relevant if an appropriate option is available; ask what it involves, including visits, monitoring and alternatives.

New neurological symptoms need prompt medical assessment. Seek emergency help for a first seizure, a seizure that does not stop, sudden weakness, new trouble speaking, collapse, severe confusion, repeated vomiting or a rapidly worsening headache. Do not drive during a suspected seizure or sudden neurological event. After treatment, report fever, wound changes, increasing drowsiness or new weakness to the treating team.

Ask where the tumour areas are, whether tissue is needed, what functions could be affected by surgery, and how swelling or seizures will be managed. Ask how radiotherapy and chemotherapy fit together, what monitoring is planned, and whether a clinical trial suits your diagnosis.